<DOC>
	<DOCNO>NCT01032902</DOCNO>
	<brief_summary>This study design evaluate performance Chembio Diagnostics Systems , Inc. DPP® HIV 1/2 rapid test . The device intend qualitatively detect presence antibody HIV-1/2 oral fluid , whole blood ( capillary venous ) , serum plasma . This study ass DPP® HIV 1/2 Screen assay 's ability detect HIV-1 .</brief_summary>
	<brief_title>Evaluation Performance Chembio Diagnostics Systems , Inc. DPP® HIV 1/2 Rapid Test</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Must least 2 year age ( upper age limit ) . Must willing able receive posttest counseling , applicable . Must sign ( give ) copy write Informed Consent form Assent form ( applicable ) . Must able sustain fingersticks venipuncture arm hand . Am life threaten condition time enrollment Have suppress immune system ( i.e . transplant patient , individual diagnose nonHIV immunosuppressive illness , etc. ) . Have participate participate clinical trial HIV vaccine . Have previously participate clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Human immunodeficiency virus</keyword>
	<keyword>Rapid Test</keyword>
	<keyword>HIV</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>